TY  - JOUR
AB  - AIM: The aim of this Phase I trial was to assess the safety, compliance, and potential efficacy of iLidcombe, a standalone internet version of the Lidcombe Program for young children who stutter. METHOD: We used a prospective single-group design involving 6 months of access to iLidcombe. Assessments occurred pretreatment and after 6 months of access. Participants were 20 parents of young children who stuttered. RESULTS: There was evidence of stuttering severity reduction after using iLidcombe for 6 months. Compliance with the program was favorable, and there was no suggestion of any psychologically adverse impact on children. CONCLUSION: The results of this Phase I trial provide a roadmap for further Phases II-IV clinical trial development.
AU  - Ross, F
AU  - Onslow, M
AU  - Jones, M
AU  - Menzies, R
AU  - Packman, A
AU  - O'Brian, S
AU  - Hearne, A
AU  - Lowe, R
DA  - 2026/04/27
DO  - 10.1044/2026_AJSLP-25-00448
EP  - 12
JO  - American Journal of Speech-Language Pathology
PB  - American Speech-Language-Hearing Association
PY  - 2026/04/27
SP  - 1
TI  - A Phase I trial of iLidcombe: Online treatment for young children who stutter
Y1  - 2026/04/27
Y2  - 2026/06/17
ER  -